<DOC>
	<DOCNO>NCT01861197</DOCNO>
	<brief_summary>Efficacy Dovitinib Squamous NSCLC .</brief_summary>
	<brief_title>Phase II Study Dovitinib FGFR1 Amplified Squamous Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<criteria>histologically confirm squamous NSCLC Previously treat one two line chemotherapy FGFR amplification ( FISH &gt; 5 copy gene ) 20 year old ECOG PS 02 active infection uncontrolled brain metastasis unstable angina MI</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>Dovitinib</keyword>
	<keyword>Squamous NSCLC</keyword>
</DOC>